SEGMENT INFORMATION (Tables)

6 Months Ended

Mar. 30, 2018

Segment Reporting [Abstract]

Operating Results Information for Each Business Segment

The following table summarizes select operating results information for each reportable segment:

	Three Months Ended						Six Months Ended
(In millions)	March 30, 2018			March 31, 2017			March 30, 2018			March 31, 2017
Revenues
Oncology Systems	$	698.0		$	631.9		$	1,347.4		$	1,203.1
Varian Particle Therapy	31.9			31.3			61.0			61.6
Total Company	$	729.9		$	663.2		$	1,408.4		$	1,264.7
Operating Earnings
Oncology Systems	$	143.1		$	122.9		$	281.3		$	239.0
Varian Particle Therapy	(17.5		)	(19.8		)	(32.7		)	(70.1		)
Total reportable segments	125.6			103.1			248.6			168.9
Unallocated corporate	(31.3		)	(13.0		)	(32.9		)	(61.4		)
Total Company	$	94.3		$	90.1		$	215.7		$	107.5

Schedule of Disaggregation of Revenue

The Company disaggregates its revenues from contracts by major product categories and by geographic region for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.

Total Revenues by product type	Three Months Ended March 30, 2018						Six Months Ended March 30, 2018
(In millions)	Oncology Systems		Varian Particle Therapy		Total		Oncology Systems		Varian Particle Therapy		Total
Hardware	$	311.6	$	30.1	$	341.7	$	604.7	$	57.4	$	662.1
Software (1)	126.7		—		126.7		241.8		—		241.8
Service	259.7		1.8		261.5		500.9		3.6		504.5
Total Revenues	$	698.0	$	31.9	$	729.9	$	1,347.4	$	61.0	$	1,408.4

⁽¹⁾ Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).

Total Revenues by product type	Three Months Ended March 31, 2017						Six Months Ended March 31, 2017
(In millions)	Oncology Systems		Varian Particle Therapy		Total		Oncology Systems		Varian Particle Therapy		Total
Hardware	$	284.5	$	30.1	$	314.6	$	523.1	$	56.9	$	580.0
Software (1)	118.4		—		118.4		230.6		—		230.6
Service	229.0		1.2		230.2		449.4		4.7		454.1
Total Revenues	$	631.9	$	31.3	$	663.2	$	1,203.1	$	61.6	$	1,264.7

⁽¹⁾  Includes software support agreements that are recorded in revenues from service in the Condensed Consolidated Statements of Earnings (Loss).

Total Revenues by geographical region	Three Months Ended March 30, 2018						Six Months Ended March 30, 2018
(In millions)	Oncology Systems		Varian Particle Therapy		Total		Oncology Systems		Varian Particle Therapy		Total
Americas	$	321.2	$	19.0	$	340.2	$	658.6	$	38.3	$	696.9
EMEA	241.2		12.6		253.8		424.7		22.1		446.8
APAC	135.6		0.3		135.9		264.1		0.6		264.7
Total Revenues	$	698.0	$	31.9	$	729.9	$	1,347.4	$	61.0	$	1,408.4
North America	$	299.6	$	19.0	$	318.6	$	625.9	$	38.3	$	664.2
International	398.4		12.9		411.3		721.5		22.7		744.2
Total Revenues	$	698.0	$	31.9	$	729.9	$	1,347.4	$	61.0	$	1,408.4

Total Revenues by geographical region	Three Months Ended March 31, 2017						Six Months Ended March 31, 2017
(In millions)	Oncology Systems		Varian Particle Therapy		Total		Oncology Systems		Varian Particle Therapy		Total
Americas	$	332.0	$	9.6	$	341.6	$	622.8	$	17.0	$	639.8
EMEA	167.5		17.8		185.3		336.5		32.8		369.3
APAC	132.4		3.9		136.3		243.8		11.8		255.6
Total Revenues	$	631.9	$	31.3	$	663.2	$	1,203.1	$	61.6	$	1,264.7
North America	$	309.7	$	9.6	319.3		$	584.7	$	17.0	601.7
International	322.2		21.7		343.9		618.4		44.6		663.0
Total Revenues	$	631.9	$	31.3	$	663.2	$	1,203.1	$	61.6	$	1,264.7

Timing of revenue recognition	Three Months Ended March 30, 2018						Six Months Ended March 30, 2018
(In millions)	Products transferred at a point in time		Products and Services transferred over time		Total		Products transferred at a point in time		Products and Services transferred over time		Total
Oncology Systems	$	363.7	$	334.3	$	698.0	$	702.0	$	645.4	$	1,347.4
Varian Particle Therapy	—		31.9		31.9		—		61.0		61.0
Total Revenues	$	363.7	$	366.2	$	729.9	$	702.0	$	706.4	$	1,408.4

Timing of revenue recognition	Three Months Ended March 31, 2017						Six Months Ended March 31, 2017
(In millions)	Products Transferred at a Point in Time		Products and Services Transferred Over Time		Total		Products Transferred at a Point in Time		Products and Services Transferred Over Time		Total
Oncology Systems	$	334.8	$	297.1	$	631.9	$	617.2	$	585.9	$	1,203.1
Varian Particle Therapy	—		31.3		31.3		—		61.6		61.6
Total Revenues	$	334.8	$	328.4	$	663.2	$	617.2	$	647.5	$	1,264.7